← Open Payments lookup

DEANGELLA SIMPSON: Open Payments

NPI 1700328135 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$592 in 18 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $116 · 2025 $592

Food & beverage: $592
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$179
Alkermes, Inc.3$173
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$146
Teva Pharmaceuticals USA, Inc.2$34
Otsuka America Pharmaceutical, Inc.1$28
E.R. Squibb & Sons, L.L.C.1$17
Luye Pharma (USA) Ltd.1$16

Products named: INGREZZA, CAPLYTA, LYBALVI, ARISTADA, UZEDY, ABILIFY MAINTENA, COBENFY, ERZOFRI EXTENDED-RELEASE.

Industry payments across MI — which companies pay providers there.